Gordon Carl L
Director
Conversion
Calculated transaction value
$0
1,039,996 shares @ $0
Traded
Aug 10, 2026
Filed
Aug 12, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
Blossomhill Therapeutics, Inc.
BLSM
Transactions reported in official disclosures
43 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Gordon Carl L Director | Aug 12, 2026 2-day lag | Conversion Aug 10, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Gordon Carl L Director | Aug 12, 2026 2-day lag | Buy Aug 10, 2026 | $10M Filed shares x price | SEC Form 4 View filing | |
| Gordon Carl L Director | Aug 12, 2026 2-day lag | Conversion Aug 10, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Gordon Carl L Director | Aug 12, 2026 2-day lag | Conversion Aug 10, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Gordon Carl L Director | Aug 12, 2026 2-day lag | Conversion Aug 10, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Orbimed Advisors Llc Director | Aug 12, 2026 2-day lag | Conversion Aug 10, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Orbimed Advisors Llc Director | Aug 12, 2026 2-day lag | Conversion Aug 10, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Orbimed Advisors Llc Director | Aug 12, 2026 2-day lag | Conversion Aug 10, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Orbimed Advisors Llc Director | Aug 12, 2026 2-day lag | Conversion Aug 10, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Orbimed Advisors Llc Director | Aug 12, 2026 2-day lag | Buy Aug 10, 2026 | $10M Filed shares x price | SEC Form 4 View filing | |
| Schmid John P. Director | Aug 10, 2026 Same-day filing | Buy Aug 10, 2026 | $96K Filed shares x price | SEC Form 4 View filing | |
| Gordon Carl L Director | Aug 10, 2026 4-day lag | Award Aug 6, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Chen Bihua Director / Ten Percent Owner | Aug 10, 2026 Same-day filing | Conversion Aug 10, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Chen Bihua Director / Ten Percent Owner | Aug 10, 2026 Same-day filing | Conversion Aug 10, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Chen Bihua Director / Ten Percent Owner | Aug 10, 2026 Same-day filing | Conversion Aug 10, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Chen Bihua Director / Ten Percent Owner | Aug 10, 2026 Same-day filing | Conversion Aug 10, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Chen Bihua Director / Ten Percent Owner | Aug 10, 2026 Same-day filing | Buy Aug 10, 2026 | $5M Filed shares x price | SEC Form 4 View filing | |
| Chen Bihua Director / Ten Percent Owner | Aug 10, 2026 4-day lag | Award Aug 6, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Agrawal Sundeep Director | Aug 10, 2026 Same-day filing | Conversion Aug 10, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Agrawal Sundeep Director | Aug 10, 2026 Same-day filing | Conversion Aug 10, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Agrawal Sundeep Director | Aug 10, 2026 4-day lag | Award Aug 6, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Keyes Jason A Chief Financial Officer | Aug 10, 2026 Same-day filing | Buy Aug 10, 2026 | $11.2K Filed shares x price | SEC Form 4 View filing | |
| Keyes Jason A Chief Financial Officer | Aug 10, 2026 4-day lag | Award Aug 6, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Liptak Vincent Paul General Counsel | Aug 10, 2026 Same-day filing | Buy Aug 10, 2026 | $35.2K Filed shares x price | SEC Form 4 View filing | |
| Liptak Vincent Paul General Counsel | Aug 10, 2026 Same-day filing | Conversion Aug 10, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Liptak Vincent Paul General Counsel | Aug 10, 2026 Same-day filing | Conversion Aug 10, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Liptak Vincent Paul General Counsel | Aug 10, 2026 3-day lag | Buy Aug 7, 2026 | $39.5K Filed shares x price | SEC Form 4 View filing | |
| Liptak Vincent Paul General Counsel | Aug 10, 2026 4-day lag | Award Aug 6, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Oxnard Geoffrey Raymond Chief Medical Officer | Aug 10, 2026 4-day lag | Award Aug 6, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Li Yishan Executive Chairman | Aug 10, 2026 Same-day filing | Conversion Aug 10, 2026 | Not reported Reported range | SEC Form 4 View filing |
Gordon Carl L
Director
Buy
Calculated transaction value
$10M
625,000 shares @ $16
Traded
Aug 10, 2026
Filed
Aug 12, 2026
Gordon Carl L
Director
Conversion
Calculated transaction value
$0
1,049,283 shares @ $0
Traded
Aug 10, 2026
Filed
Aug 12, 2026
Gordon Carl L
Director
Conversion
Reported value range
Not reported
1,049,283 shares
Traded
Aug 10, 2026
Filed
Aug 12, 2026
Gordon Carl L
Director
Conversion
Reported value range
Not reported
1,039,996 shares
Traded
Aug 10, 2026
Filed
Aug 12, 2026
Orbimed Advisors Llc
Director
Conversion
Calculated transaction value
$0
1,039,996 shares @ $0
Traded
Aug 10, 2026
Filed
Aug 12, 2026
Orbimed Advisors Llc
Director
Conversion
Reported value range
Not reported
1,049,283 shares
Traded
Aug 10, 2026
Filed
Aug 12, 2026
Orbimed Advisors Llc
Director
Conversion
Reported value range
Not reported
1,039,996 shares
Traded
Aug 10, 2026
Filed
Aug 12, 2026
Orbimed Advisors Llc
Director
Conversion
Calculated transaction value
$0
1,049,283 shares @ $0
Traded
Aug 10, 2026
Filed
Aug 12, 2026
Orbimed Advisors Llc
Director
Buy
Calculated transaction value
$10M
625,000 shares @ $16
Traded
Aug 10, 2026
Filed
Aug 12, 2026
Schmid John P.
Director
Buy
Calculated transaction value
$96K
6,000 shares @ $16
Traded
Aug 10, 2026
Filed
Aug 10, 2026
Gordon Carl L
Director
Award
Calculated transaction value
$0
23,904 shares @ $0
Traded
Aug 6, 2026
Filed
Aug 10, 2026
Chen Bihua
Director / Ten Percent Owner
Conversion
Reported value range
Not reported
1,701,541 shares
Traded
Aug 10, 2026
Filed
Aug 10, 2026
Chen Bihua
Director / Ten Percent Owner
Conversion
Reported value range
Not reported
1,599,993 shares
Traded
Aug 10, 2026
Filed
Aug 10, 2026
Chen Bihua
Director / Ten Percent Owner
Conversion
Reported value range
Not reported
1,599,993 shares
Traded
Aug 10, 2026
Filed
Aug 10, 2026
Chen Bihua
Director / Ten Percent Owner
Conversion
Reported value range
Not reported
1,701,541 shares
Traded
Aug 10, 2026
Filed
Aug 10, 2026
Chen Bihua
Director / Ten Percent Owner
Buy
Calculated transaction value
$5M
312,500 shares @ $16
Traded
Aug 10, 2026
Filed
Aug 10, 2026
Chen Bihua
Director / Ten Percent Owner
Award
Calculated transaction value
$0
23,904 shares @ $0
Traded
Aug 6, 2026
Filed
Aug 10, 2026
Agrawal Sundeep
Director
Conversion
Reported value range
Not reported
578,524 shares
Traded
Aug 10, 2026
Filed
Aug 10, 2026
Agrawal Sundeep
Director
Conversion
Reported value range
Not reported
578,524 shares
Traded
Aug 10, 2026
Filed
Aug 10, 2026
Agrawal Sundeep
Director
Award
Calculated transaction value
$0
23,904 shares @ $0
Traded
Aug 6, 2026
Filed
Aug 10, 2026
Keyes Jason A
Chief Financial Officer
Buy
Calculated transaction value
$11.2K
700 shares @ $16
Traded
Aug 10, 2026
Filed
Aug 10, 2026
Keyes Jason A
Chief Financial Officer
Award
Calculated transaction value
$0
56,746 shares @ $0
Traded
Aug 6, 2026
Filed
Aug 10, 2026
Liptak Vincent Paul
General Counsel
Buy
Calculated transaction value
$35.2K
2,200 shares @ $16
Traded
Aug 10, 2026
Filed
Aug 10, 2026
Liptak Vincent Paul
General Counsel
Conversion
Reported value range
Not reported
22,687 shares
Traded
Aug 10, 2026
Filed
Aug 10, 2026
Liptak Vincent Paul
General Counsel
Conversion
Reported value range
Not reported
22,687 shares
Traded
Aug 10, 2026
Filed
Aug 10, 2026
Liptak Vincent Paul
General Counsel
Buy
Calculated transaction value
$39.5K
2,500 shares @ $15.8
Traded
Aug 7, 2026
Filed
Aug 10, 2026
Liptak Vincent Paul
General Counsel
Award
Calculated transaction value
$0
46,561 shares @ $0
Traded
Aug 6, 2026
Filed
Aug 10, 2026
Oxnard Geoffrey Raymond
Chief Medical Officer
Award
Calculated transaction value
$0
61,783 shares @ $0
Traded
Aug 6, 2026
Filed
Aug 10, 2026
Li Yishan
Executive Chairman
Conversion
Reported value range
Not reported
113,435 shares
Traded
Aug 10, 2026
Filed
Aug 10, 2026